Literature DB >> 10668202

The yin-yang of PR-domain family genes in tumorigenesis.

G L Jiang1, S Huang.   

Abstract

Cancer is essentially caused by alterations in normal cellular genes. Multiple gene changes involving at least two types of cancer genes, protooncogenes and tumor suppressor genes, are required for the clonal expansion of a malignant cell. This discussion focuses on the recently recognized role of a small but expanding family of PR-domain genes in tumorigenesis. The protein products of these genes are involved in human cancers in an unusual yin-yang fashion. Two products are normally produced from a PR-domain family member which differ by the presence or absence of the PR domain; the PR-plus product is disrupted or underexpressed whereas the PR-minus product is present or overexpressed in cancer cells. This imbalance in the amount of the two products, a result of either genetic or epigenetic events, appears to be an important cause of malignancy.

Entities:  

Mesh:

Year:  2000        PMID: 10668202     DOI: 10.14670/HH-15.109

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  22 in total

Review 1.  Evi-1 as a critical regulator of leukemic cells.

Authors:  Susumu Goyama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-06-08       Impact factor: 2.490

2.  Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Authors:  Boris Calmels; Cole Ferguson; Mikko O Laukkanen; Rima Adler; Marion Faulhaber; Hyeoung-Joon Kim; Stephanie Sellers; Peiman Hematti; Manfred Schmidt; Christof von Kalle; Keiko Akagi; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

3.  Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

Authors:  Ying-Tao Zhang; Yi-Ping Geng; Le Zhou; Bao-Chang Lai; Lv-Sheng Si; Yi-Li Wang
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

4.  Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias.

Authors:  Sawcène Hazourli; Pierre Chagnon; Martin Sauvageau; Raouf Fetni; Lambert Busque; Josée Hébert
Journal:  Genes Chromosomes Cancer       Date:  2006-11       Impact factor: 5.006

5.  Variety is the splice of life.

Authors:  Anne Hamik; Mukesh K Jain
Journal:  J Mol Cell Cardiol       Date:  2007-09-29       Impact factor: 5.000

6.  Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.

Authors:  R B Chadwick; G L Jiang; G A Bennington; B Yuan; C K Johnson; M W Stevens; T H Niemann; P Peltomaki; S Huang; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  DNA methylation and carcinogenesis of PRDM5 in cervical cancer.

Authors:  Hai-Yan Cheng; Xiu-Wei Chen; Li Cheng; Yun-Duo Liu; Ge Lou
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

8.  Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.

Authors:  Yang Du; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

9.  Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.

Authors:  Danielle C Shing; Maurizio Trubia; Francesco Marchesi; Enrico Radaelli; Elena Belloni; Cinzia Tapinassi; Eugenio Scanziani; Cristina Mecucci; Barbara Crescenzi; Idoya Lahortiga; Maria D Odero; Giuseppe Zardo; Alicja Gruszka; Saverio Minucci; Pier Paolo Di Fiore; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.

Authors:  Torsten A Konrad; Anna Karger; Hubert Hackl; Ilse Schwarzinger; Irene Herbacek; Rotraud Wieser
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.